Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Varbella

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 21, 2019
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomesMario Iannaccone, Fabrizio D'Ascenzo, Guglielmo Gallone, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2026
[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy]Federico Nardi, Giuseppe Patti, Giorgio Quadri, et al.
The American Journal of Cardiology|January 1, 2020
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary BifurcationsFabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, et al.
International Journal of Cardiology|April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 29, 2019
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI RegistryOvidio De Filippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 21, 2019
Impact of structural features of very thin stents implanted in unprotected left main or coronary bifurcations on clinical outcomesMario Iannaccone, Fabrizio D'Ascenzo, Guglielmo Gallone, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2026
[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy]Federico Nardi, Giuseppe Patti, Giorgio Quadri, et al.
The American Journal of Cardiology|January 1, 2020
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary BifurcationsFabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, et al.
International Journal of Cardiology|April 12, 2019
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life)Carloalberto Biolè, Zenon Huczek, Ivan Nuñez-Gil, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 10, 2025
Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary interventionPhilipp Jakob, Ferdinando Varbella, Axel Linke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2026
Impact of renal dysfunction on immediate versus staged revascularization of non-culprit lesions in patients with ST segment elevation myocardial infarction: a pre-specified subgroup analysis of the randomized MULTISTARS AMI trialMiklos Rohla, Kurt Huber, Ferdinando Varbella, et al.
The New England Journal of Medicine|August 27, 2023
Timing of Complete Revascularization with Multivessel PCI for Myocardial InfarctionBarbara E Stähli, Ferdinando Varbella, Axel Linke, et al.
Pageof 23